Buscar Close Search
Page Menu

William A. Flavahan, PhD

Research Focus - Epigenetics and Chromatin Topology in Cancer

  • Identify epigenetic driver lesions in cancer
  • Develop and utilize tools for epigenome editing
  • Characterize cancer-associated defects in the three-dimensional structure of the genome
  • Discover the effects of tumor-associated microenvironment (especially metabolism) on the epigenome
  • Develop methods to target epigenetically-driven phenotypes such as cancer stem cells and drug-tolerant persisters

Representative Publication  

Flavahan WA, Drier Y, et al. Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs. Nature. 2019;575(7781):229-233.

Read Publication

More Publications

In the News

Getting Results…
  • UMass Chan cancer biologist receives New Innovator Award for developing DNA sequencing technology

    UMass Chan cancer biologist receives New Innovator Award for developing DNA sequencing technology

    William Flavahan, PhD, is one of 40 recipients of the $1.5 million NIH Director’s New Innovator Award, designed to support early career investigators who are proposing bold research.

    Read more
  • William Flavahan receives Distinguished Scientist Award for groundbreaking brain cancer research

    William Flavahan receives Distinguished Scientist Award for groundbreaking brain cancer research

    William Flavahan, PhD, has received a four-year, $600,000 award from the Sontag Foundation to advance his studies of the genetic processes leading to brain tumors.

    Read more